Click here to get full coverage on International Tax Competitiveness Index 2025 - Tax Foundation

International Tax Competitiveness Index 2025  Tax Foundation

International Tax Competitiveness Index 2025 - Tax Foundation

Click here to get full coverage on itci-20241231 - SEC.gov

itci-20241231 - SEC.gov

Click here to get full coverage on Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now - Yahoo Finance

Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now  Yahoo Finance

Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now - Yahoo Finance

Click here to get full coverage on J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion - CNBC

J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion  CNBC

J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion - CNBC

Click here to get full coverage on J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal - Reuters

J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal  Reuters

J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal - Reuters

Click here to get full coverage on Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B - Investopedia

Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B  Investopedia

Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B - Investopedia

Click here to get full coverage on Johnson & Johnson Acquires Intra-Cellular Therapies: What You Need to Know (ITCI Merger) - tradingcalendar.com

Johnson & Johnson Acquires Intra-Cellular Therapies: What You Need to Know (ITCI Merger)  tradingcalendar.com

Johnson & Johnson Acquires Intra-Cellular Therapies: What You Need to Know (ITCI Merger) - tradingcalendar.com

Click here to get full coverage on J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind month: filing - Fierce Pharma

J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind month: filing  Fierce Pharma

J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind month: filing - Fierce Pharma

Click here to get full coverage on ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan - Yahoo Finance

ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan  Yahoo Finance

ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies acquired by Johnson & Johnson for $14.6 billion - Investing.com

Intra-Cellular Therapies acquired by Johnson & Johnson for $14.6 billion  Investing.com

Intra-Cellular Therapies acquired by Johnson & Johnson for $14.6 billion - Investing.com

Click here to get full coverage on Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now - Yahoo Finance

Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now  Yahoo Finance

Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies (ITCI): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Intra-Cellular Therapies (ITCI): Among the Best Biotech Stocks to Buy According to Billionaires  Yahoo Finance

Intra-Cellular Therapies (ITCI): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Click here to get full coverage on ITCI Stock Rises 15% on Settling Caplyta Patent Litigation With Sandoz - Yahoo Finance

ITCI Stock Rises 15% on Settling Caplyta Patent Litigation With Sandoz  Yahoo Finance

ITCI Stock Rises 15% on Settling Caplyta Patent Litigation With Sandoz - Yahoo Finance

Click here to get full coverage on ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD - Yahoo Finance

ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD  Yahoo Finance

ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD - Yahoo Finance

Click here to get full coverage on ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales - Yahoo Finance

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales  Yahoo Finance

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies, Inc. (ITCI): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Psychedelic Stocks to Buy in 2025  Yahoo Finance

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer - Yahoo Finance

Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer  Yahoo Finance

Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer - Yahoo Finance

Click here to get full coverage on Intra-Cellular's (ITCI) Caplyta Aids Sales, Overreliance a Woe - Yahoo Finance

Intra-Cellular's (ITCI) Caplyta Aids Sales, Overreliance a Woe  Yahoo Finance

Intra-Cellular's (ITCI) Caplyta Aids Sales, Overreliance a Woe - Yahoo Finance

Click here to get full coverage on Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe - Yahoo Finance

Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe  Yahoo Finance

Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies Soars 32% With Johnson & Johnson's $14.6B Acquisition - Yahoo Finance

Intra-Cellular Therapies Soars 32% With Johnson & Johnson's $14.6B Acquisition  Yahoo Finance

Intra-Cellular Therapies Soars 32% With Johnson & Johnson's $14.6B Acquisition - Yahoo Finance

Click here to get full coverage on ITCI Stock Price, News & Analysis - Stock Titan

ITCI Stock Price, News & Analysis  Stock Titan

ITCI Stock Price, News & Analysis - Stock Titan

Click here to get full coverage on Latest ITCI News - Intra-Cellular Therapies Reports Fourth Qua... - Stock Titan

Latest ITCI News - Intra-Cellular Therapies Reports Fourth Qua...  Stock Titan

Latest ITCI News - Intra-Cellular Therapies Reports Fourth Qua... - Stock Titan

Click here to get full coverage on Intra-Cellular Therapies Is On Fire (NASDAQ:ITCI) - Seeking Alpha

Intra-Cellular Therapies Is On Fire (NASDAQ:ITCI)  Seeking Alpha

Intra-Cellular Therapies Is On Fire (NASDAQ:ITCI) - Seeking Alpha

Click here to get full coverage on Intra-Cellular Therapies (NASDAQ: ITCI): A Comprehensive Analysis - Barchart

Intra-Cellular Therapies (NASDAQ: ITCI): A Comprehensive Analysis  Barchart

Intra-Cellular Therapies (NASDAQ: ITCI): A Comprehensive Analysis - Barchart

Click here to get full coverage on Intra-cellular Therapies Stock Price Forecast. Should You Buy ITCI? - StockInvest.us

Intra-cellular Therapies Stock Price Forecast. Should You Buy ITCI?  StockInvest.us

Intra-cellular Therapies Stock Price Forecast. Should You Buy ITCI? - StockInvest.us

Click here to get full coverage on J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies - MedCity News

J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies  MedCity News

J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies - MedCity News

Click here to get full coverage on Intra-Cellular Therapies progresses in Johnson & Johnson merger - Investing.com

Intra-Cellular Therapies progresses in Johnson & Johnson merger  Investing.com

Intra-Cellular Therapies progresses in Johnson & Johnson merger - Investing.com

Click here to get full coverage on What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies (ITCI) - Seeking Alpha

What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies (ITCI)  Seeking Alpha

What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies (ITCI) - Seeking Alpha

Click here to get full coverage on Intra-Cellular's (ITCI) Caplyta Aids Growth, Overdependence a Woe - Yahoo Finance

Intra-Cellular's (ITCI) Caplyta Aids Growth, Overdependence a Woe  Yahoo Finance

Intra-Cellular's (ITCI) Caplyta Aids Growth, Overdependence a Woe - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz - Yahoo Finance

Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz  Yahoo Finance

Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies Reports Third Quarter 2024 - GlobeNewswire

Intra-Cellular Therapies Reports Third Quarter 2024  GlobeNewswire

Intra-Cellular Therapies Reports Third Quarter 2024 - GlobeNewswire

Click here to get full coverage on Intra-Cellular Therapies Submits Supplemental New Drug - GlobeNewswire

Intra-Cellular Therapies Submits Supplemental New Drug  GlobeNewswire

Intra-Cellular Therapies Submits Supplemental New Drug - GlobeNewswire

Click here to get full coverage on Intra-Cellular Therapies and Sandoz Reach Settlement in CAPLYTA Patent Litigation - Quiver Quantitative

Intra-Cellular Therapies and Sandoz Reach Settlement in CAPLYTA Patent Litigation  Quiver Quantitative

Intra-Cellular Therapies and Sandoz Reach Settlement in CAPLYTA Patent Litigation - Quiver Quantitative

Click here to get full coverage on J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports - Reuters

J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports  Reuters

J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports - Reuters

Click here to get full coverage on JPM25: Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B - Fierce Pharma

JPM25: Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B  Fierce Pharma

JPM25: Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B - Fierce Pharma

Click here to get full coverage on Caplyta Litigation Settlement Sends ITCI Stock Soaring: What’s Next? - timothysykes.com

Caplyta Litigation Settlement Sends ITCI Stock Soaring: What’s Next?  timothysykes.com

Caplyta Litigation Settlement Sends ITCI Stock Soaring: What’s Next? - timothysykes.com

Click here to get full coverage on Intra-Cellular Therapies: Increased Confidence In MDD After Study 403 Success (ITCI) - Seeking Alpha

Intra-Cellular Therapies: Increased Confidence In MDD After Study 403 Success (ITCI)  Seeking Alpha

Intra-Cellular Therapies: Increased Confidence In MDD After Study 403 Success (ITCI) - Seeking Alpha

Click here to get full coverage on Here's Why Intra-Cellular Therapies Rose as Much as 176.8% Today - The Motley Fool

Here's Why Intra-Cellular Therapies Rose as Much as 176.8% Today  The Motley Fool

Here's Why Intra-Cellular Therapies Rose as Much as 176.8% Today - The Motley Fool

Click here to get full coverage on Insider Sell Alert: EVP Michael Halstead Sells 50,000 Shares of Intra-Cellular Therapies Inc (ITCI) - Yahoo Finance

Insider Sell Alert: EVP Michael Halstead Sells 50,000 Shares of Intra-Cellular Therapies Inc (ITCI)  Yahoo Finance

Insider Sell Alert: EVP Michael Halstead Sells 50,000 Shares of Intra-Cellular Therapies Inc (ITCI) - Yahoo Finance

Click here to get full coverage on ITCI Stock Price, Quote & Chart | INTRA-CELLULAR THERAPIES INC (NASDAQ:ITCI) - ChartMill

ITCI Stock Price, Quote & Chart | INTRA-CELLULAR THERAPIES INC (NASDAQ:ITCI)  ChartMill

ITCI Stock Price, Quote & Chart | INTRA-CELLULAR THERAPIES INC (NASDAQ:ITCI) - ChartMill

Click here to get full coverage on Intra-Cellular Therapies Announces Closing of $575 Million - GlobeNewswire

Intra-Cellular Therapies Announces Closing of $575 Million  GlobeNewswire

Intra-Cellular Therapies Announces Closing of $575 Million - GlobeNewswire

Click here to get full coverage on Intra-Cellular Therapies - ITCI - Stock Price & News - The Motley Fool

Intra-Cellular Therapies - ITCI - Stock Price & News  The Motley Fool

Intra-Cellular Therapies - ITCI - Stock Price & News - The Motley Fool

Click here to get full coverage on J&J punts $14.6 billion on buy of Intra-Cellular Therapies - The Pharma Letter

J&J punts $14.6 billion on buy of Intra-Cellular Therapies  The Pharma Letter

J&J punts $14.6 billion on buy of Intra-Cellular Therapies - The Pharma Letter

Click here to get full coverage on ITCI Stock on the Rise: Analyzing the Latest Strategy and Market Response - timothysykes.com

ITCI Stock on the Rise: Analyzing the Latest Strategy and Market Response  timothysykes.com

ITCI Stock on the Rise: Analyzing the Latest Strategy and Market Response - timothysykes.com

Click here to get full coverage on Sharon Mates - Forbes

Sharon Mates - Forbes

Click here to get full coverage on J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug - Investor's Business Daily

J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug  Investor's Business Daily

J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug - Investor's Business Daily

Click here to get full coverage on Johnson & Johnson to Expand Neuroscience Portfolio with US$14.6 Billion Acquisition - Investing News Network

Johnson & Johnson to Expand Neuroscience Portfolio with US$14.6 Billion Acquisition  Investing News Network

Johnson & Johnson to Expand Neuroscience Portfolio with US$14.6 Billion Acquisition - Investing News Network

Click here to get full coverage on Intra-Cellular Therapies Promotes Dr. Michael Halstead to President - Contract Pharma

Intra-Cellular Therapies Promotes Dr. Michael Halstead to President  Contract Pharma

Intra-Cellular Therapies Promotes Dr. Michael Halstead to President - Contract Pharma

Click here to get full coverage on Intra-Cellular Therapies Appoints Sanjeev Narula as Chief Financial Officer - citybiz

Intra-Cellular Therapies Appoints Sanjeev Narula as Chief Financial Officer  citybiz

Intra-Cellular Therapies Appoints Sanjeev Narula as Chief Financial Officer - citybiz

Click here to get full coverage on Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update - Yahoo Finance

Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update  Yahoo Finance

Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies Announces U.S. FDA Approval of - GlobeNewswire

Intra-Cellular Therapies Announces U.S. FDA Approval of  GlobeNewswire

Intra-Cellular Therapies Announces U.S. FDA Approval of - GlobeNewswire

Click here to get full coverage on Intra-Cellular Therapies: Positive MDD Data And Commercial Momentum Make It A Buy (ITCI) - Seeking Alpha

Intra-Cellular Therapies: Positive MDD Data And Commercial Momentum Make It A Buy (ITCI)  Seeking Alpha

Intra-Cellular Therapies: Positive MDD Data And Commercial Momentum Make It A Buy (ITCI) - Seeking Alpha

Click here to get full coverage on Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference  GlobeNewswire

Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Click here to get full coverage on SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders - GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders  GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders - GlobeNewswire

Click here to get full coverage on Here is What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI) - Insider Monkey

Here is What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI)  Insider Monkey

Here is What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI) - Insider Monkey

Click here to get full coverage on Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results  GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire

Click here to get full coverage on Intra-Cellular tanks on PhIII schizophrenia failure - Fierce Biotech

Intra-Cellular tanks on PhIII schizophrenia failure  Fierce Biotech

Intra-Cellular tanks on PhIII schizophrenia failure - Fierce Biotech

Click here to get full coverage on J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders - Yahoo Finance

J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders  Yahoo Finance

J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders - Yahoo Finance

Click here to get full coverage on Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal - BioWorld News

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal  BioWorld News

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal - BioWorld News

Click here to get full coverage on Phase III win for Intra-Cellular's Caplyta for major depressive disorder - BioWorld News

Phase III win for Intra-Cellular's Caplyta for major depressive disorder  BioWorld News

Phase III win for Intra-Cellular's Caplyta for major depressive disorder - BioWorld News

Click here to get full coverage on Intra-Cellular Therapies' Candidate Fails in Phase III Study - Yahoo Finance

Intra-Cellular Therapies' Candidate Fails in Phase III Study  Yahoo Finance

Intra-Cellular Therapies' Candidate Fails in Phase III Study - Yahoo Finance

Click here to get full coverage on Heavy Early Morning Activity On Intra-Cellular Therapies (ITCI) - thestreet.com

Heavy Early Morning Activity On Intra-Cellular Therapies (ITCI)  thestreet.com

Heavy Early Morning Activity On Intra-Cellular Therapies (ITCI) - thestreet.com

Click here to get full coverage on Intra-Cellular Therapies’ Stock Surge: What’s Fueling the Momentum? - timothysykes.com

Intra-Cellular Therapies’ Stock Surge: What’s Fueling the Momentum?  timothysykes.com

Intra-Cellular Therapies’ Stock Surge: What’s Fueling the Momentum? - timothysykes.com

Click here to get full coverage on Intra-Cellular Therapies Announces Positive Topline Results - GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results  GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results - GlobeNewswire

Click here to get full coverage on Estonia tops tax competitiveness index - Central European Times

Estonia tops tax competitiveness index  Central European Times

Estonia tops tax competitiveness index - Central European Times

Click here to get full coverage on Intra-Cellular Therapies Announces Positive Phase 3 Topline - GlobeNewswire

Intra-Cellular Therapies Announces Positive Phase 3 Topline  GlobeNewswire

Intra-Cellular Therapies Announces Positive Phase 3 Topline - GlobeNewswire

Click here to get full coverage on Intra-Cellular Therapies (ITCI) Dividend History, Date, and Yield - CoinCodex

Intra-Cellular Therapies (ITCI) Dividend History, Date, and Yield  CoinCodex

ITCI

Price Chart

Key Statistics

Technicals

About ITCI

Latest News

International Tax Competitiveness Index 2025 - Tax Foundation

itci-20241231 - SEC.gov

Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers